Cat. No. |
Product Name |
Information |
PC-44297 |
Clopidogrel
P2Y12 antagonist
|
Clopidogrel (Clopidogrelum) is a thienopyridine-class antiplatelet agent that works by irreversibly inhibiting P2Y12 receptor on platelets. |
PC-42218 |
Ticagrelor
P2Y12 antagonist
|
Ticagrelor (AZD6140) is a potent, selective, reversible and oral P2Y12 receptor antagonist with pKi of 8.7. |
PC-23318 |
PSB-18422
GPR17 agonist
|
PSB-18422 is a potent, selective agonist of orphan receptor GPR17 with EC50 of 27.9 nM, selective over human P2Y receptor subtypes. |
PC-23316 |
PSB-24040
GPR17 antagonist
|
PSB-24040 is a potent antagonist of orphan receptor GPR17 with Ki of 83.2 nM, and pIC50 of 7.48 in calcium mobilization assays. |
PC-23315 |
PSB-22269
GPR17 antagonist
|
PSB-22269 is a potent antagonist of orphan receptor GPR17 with Ki of 8.91 nM, and pIC50 of 6.9 in calcium mobilization assays. |
PC-22687 |
Vicagrel
P2Y12 antagonist
|
Vicagrel is a highly potent and orally bioavailable antiplatelet agent, irreversible P2Y12 receptor antagonist. |
PC-22477 |
P2Y2R/GPR17 antagonist 14m
P2Y2R/GPR17 antagonist
|
P2Y2R/GPR17 antagonist 14m is a potent, dual P2Y2R/GPR17 antagonist with IC50 of 3.17 and 1.67 μM respectively, selective versus other closely related P2Y receptors. |
PC-22103 |
PPTN hydrochloride
P2Y14 antagonist
|
PPTN hydrochloride is a potent, highly specific antagonist of P2Y14 receptor with Ki of 0.4 nM in functional assays. |
PC-22102 |
PPTN
P2Y14 antagonist
|
PPTN is a potent, highly specific antagonist of P2Y14 receptor with Ki of 0.4 nM in functional assays. |
PC-21206 |
PSB-0739
P2Y12 antagonist
|
PSB-0739 is a high potent, non-nucleotide-derived competitive antagonist of platelet P2Y12 receptor with Ki of 24.9 nM. |
PC-20994 |
MRS2768 tetrasodium salt
P2Y2R agonist
|
MRS2768 is a selective P2Y2 receptor agonist with EC50 of 1.89 uM, shows no effect for human P2Y4 or P2Y6 receptors. |
PC-20993 |
AR-C118925
P2Y2R antagonist
|
AR-C118925 is a potent, selective, competitive P2Y2 receptor antagonist with pA2 values of 37.2 nM and 51.3 nM in calcium and β-arrestin assays, respectively. |